Rohto Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 15, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	551,014	505,369	676,888	631,946	421,488	336,849
Market Cap Growth	9.62%	-25.34%	7.11%	49.93%	25.13%	-0.24%
Enterprise Value	546,105	493,570	610,616	575,682	380,505	296,984
Last Close Price	2438.50	2196.95	2876.51	2664.47	1761.22	1393.84
PE Ratio	16.41	16.30	21.88	23.96	20.05	20.12
Forward PE	16.53	15.19	20.08	24.15	19.94	21.85
PS Ratio	1.64	1.64	2.50	2.65	2.11	1.86
PB Ratio	1.81	1.86	2.74	2.94	2.29	2.15
P/TBV Ratio	2.67	2.48	2.86	3.16	2.49	2.27
P/FCF Ratio	-	18.16	25.77	28.15	24.82	29.84
P/OCF Ratio	-	13.69	19.77	20.43	15.47	16.84
PEG Ratio	4.59	4.00	4.00	4.00	4.00	4.00
EV/Sales Ratio	1.63	1.60	2.26	2.41	1.91	1.64
EV/EBITDA Ratio	9.60	9.56	12.50	13.93	10.61	10.38
EV/EBIT Ratio	13.52	12.83	15.20	17.17	13.50	13.58
EV/FCF Ratio	-	17.73	23.25	25.64	22.41	26.31
Debt / Equity Ratio	0.17	0.19	0.04	0.05	0.12	0.05
Debt / EBITDA Ratio	0.92	0.97	0.21	0.28	0.60	0.28
Debt / FCF Ratio	-	1.80	0.40	0.52	1.26	0.72
Net Debt / Equity Ratio	-0.07	-0.10	-0.32	-0.32	-0.28	-0.29
Net Debt / EBITDA Ratio	-0.39	-0.52	-1.61	-1.65	-1.43	-1.57
Net Debt / FCF Ratio	-	-0.97	-3.00	-3.04	-3.03	-3.97
Asset Turnover	0.78	0.80	0.83	0.82	0.80	0.82
Inventory Turnover	2.31	2.47	2.59	2.72	2.71	2.55
Quick Ratio	1.35	1.55	1.82	1.75	1.74	1.79
Current Ratio	2.03	2.30	2.47	2.37	2.30	2.36
Return on Equity (ROE)	12.20%	11.94%	13.59%	13.25%	12.42%	11.31%
Return on Assets (ROA)	5.80%	6.26%	7.66%	7.17%	7.04%	6.20%
Return on Invested Capital (ROIC)	11.04%	13.63%	19.28%	18.52%	17.47%	14.91%
Return on Capital Employed (ROCE)	11.40%	11.80%	15.50%	14.60%	13.90%	12.90%
Earnings Yield	6.27%	6.13%	4.57%	4.17%	4.99%	4.97%
FCF Yield	-	5.51%	3.88%	3.55%	4.03%	3.35%
Dividend Yield	1.89%	1.64%	0.94%	0.83%	1.02%	1.00%
Payout Ratio	-	22.81%	17.70%	17.73%	16.28%	17.71%
Buyback Yield / Dilution	-1.58%	-0.04%	0.00%	0.00%	-	-0.01%
Total Shareholder Return	0.33%	1.59%	0.94%	0.83%	1.02%	1.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.